Giuseppe Tonini

10PUBLICATIONS
174CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

|May 07, 2025
Are we doing enough to treat cancer pain? The urgent need for action in oncology practice.

Massimo Aglietta, Rossana Berardi, Guido Biasco

|Jan 05, 2024
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.

Carmine Pinto, Armando Orlandi, Nicola Normanno

|Jun 28, 2023
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study.

Maurizio Muscaritoli, Alessandra Modena, Matteo Valerio

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Jan 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

Marco Tagliamento, Alessandra Gennari, Matteo Lambertini

Pageof 2